Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

cyclooxygenase/uždegimas

Nuoroda įrašoma į mainų sritį
Puslapis 1 nuo 180 rezultatus

Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD The invention herein is directed to an expansion of the use of selective inhibitors of cyclooxygenase-2 and of natural substances which inhibit cyclooxygenase-2. BACKGROUND OF THE INVENTION Prostaglandins are important mediators of inflammation that are produced at elevated levels in

Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND The present invention relates to dietary food supplements that are useful for the relief of pain or inflammation, and also for the inhibition of biochemical pathways related to pain or inflammation transmission. These food supplements contain flavonoids, and more particularly, certain

Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND The present invention relates to dietary food supplements that are useful for the relief of pain or inflammation, and also for the inhibition of biochemical pathways related to pain or inflammation transmission. These food supplements contain flavonoids, and more particularly, certain
FIELD OF THE INVENTION This invention is in the field of preventing or treating cardiovascular disorders. More specifically, this invention relates to the use of aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy in preventing or treating cardiovascular disease including
FIELD OF THE INVENTION This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to co-administration of an inhibitor of cyclooxygenase-2 and a 5-lipoxygenase inhibitor for treating inflammation and inflammation-related disorders, such as arthritis. BACKGROUND
FIELD OF THE INVENTION This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to co-administration of an inhibitor of cyclooxygenase-2 and a leukotriene A.sub.4 hydrolase inhibitor for treating inflammation and inflammation-related disorders, such as
FIELD OF THE INVENTION This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to co-administration of an inhibitor of cyclooxygenase-2 and a leukotriene A.sub.4 hydrolase inhibitor for treating inflammation and inflammation-related disorders, such as

Methods of administering anti-inflammatory cyclooxygenase-2 selective inhibitors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION Research into the mechanism of inflammatory pain led to the discovery of the biochemical pathway associated with inflammation. One such example of chronic inflammatory pain is osteoarthritis. The elucidation of this pathway led to the association of the pro-inflammatory
BACKGROUND OF THE INVENTION Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used because of their anti-inflammatory and analgesic activity. It is commonly recognized that NSAIDs exert their effect by blocking the activity of cyclooxygenase (COX), also known as prostaglandin G/H synthase
This application is a U.S. national stage of PCT/EP2011/052325 filed on Feb. 17, 2011 which claims priority to and the benefit of Italian Application No. MI2010A000318 filed on Feb. 26, 2010, the contents of which are incorporated herein by reference. FIELD OF INVENTION The present invention relates

Anti-inflammatory cyclooxygenase inhibitors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION This invention relates to therapeutic compositions that exhibit anti-inflammatory properties and inhibit cyclooxygenase. The compositions are useful for treating osteoarthritis and rheumatoid arthritis, as well as pain related to connective tissue trauma or injury. BACKGROUND

Anti-inflammatory cyclooxygenase inhibitors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION This invention relates to therapeutic compositions that exhibit anti-inflammatory properties and inhibit cyclooxygenase. The compositions are useful for treating osteoarthritis and rheumatoid arthritis, as well as pain related to connective tissue trauma or injury. BACKGROUND

Anti-inflammatory cyclooxygenase inhibitors

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION This invention relates to therapeutic compositions that exhibit anti-inflammatory properties and inhibit cyclooxygenase. The compositions are useful for treating osteoarthritis and rheumatoid arthritis, as well as pain related to connective tissue trauma or injury. BACKGROUND

Cyclooxygenase-2 selective agents useful as imaging probes and related methods

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION This invention relates to novel cyclooxygenase-2 selective agents, particularly cyclooxygenase-2 inhibitors, useful as imaging probes for positron emission tomography (PET) and single photon emission computed tomography (SPECT), as well as to related diagnostic and therapeutic

Cyclooxygenase-2 selective inhibitors, compositions and methods of use

Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION The invention describes novel nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions comprising at least one nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that
Prisijunkite prie mūsų
„Facebook“ puslapio

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

  • Dirba 55 kalbomis
  • Žolelių gydymas, paremtas mokslu
  • Vaistažolių atpažinimas pagal vaizdą
  • Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
  • Skaitykite mokslines publikacijas, susijusias su jūsų paieška
  • Ieškokite vaistinių žolelių pagal jų poveikį
  • Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais

Google Play badgeApp Store badge